Centre de Référence Maladies Rares

U1035 INSERM

Biotherapy of genetic diseases, inflammatory disorders and cancer (BMGIC)

FR: Biologie Fondamentale Appliquée à la Médecine

U1035Display navigation news FR / EN

2018

5th World Congress scleroderma

Scleroderma The 5th World Congress will be in Bordeaux from 15 to 18 February 2018.

Affiche Scérodermie

2017

ICCP 2017

The International porphyrias & Porphyrins Congress will be in Bordeaux from 25 to 28 June 2017

ICCP 2017

2016

6th Congress Autophagy BORDEAUX - 2016 - CFATG

Affiche

ANNUAL CONGRESS OF RESEARCH DERMATOLOGIQUE

ANNUAL CONGRESS OF RESEARCH DERMATOLOGIQUE : CARD Paris

6 and 7 December 2016, PALAIS DES CONGRÈS.

Vitiligo International Symposium

Vis 2016

Download

2nd Workshop of Regenerative Medicine, Bordeaux 24-26 October 2016

Affiche Congres Medecine regenerative

ESDR 2019

Bordeaux has been chosen to organize the 2019 edition of the European Society for Dermatological Research (ESDR). This annual congress gathers around 1000 investigative dermatologists and researchers, mostly from Europe, but a strong American and Asian participation is expected. Before Bordeaux, Munich (2016), Salzburg (2017), and Orlando (international Investigative Dermatology IID) will be hosting the meeting. The local organizing committee will start preparing this prestigious event very soon.

46th annual ESDR meeting

Munich, Germany
7-10 September 2016

The 46th Annual ESDR Meeting will be held at the Technical University campus in Garching, a short distance from the centre of Munich. The meeting has its own website at.

2014

Aquiderm

The newly established « AquiDerm Cellule de Transfert » funded in part by Région Aquitaine is building on previously established network with dermocosmetics companies to develop a better valorisation of the know-how of the Dermatology team. In 2014, a technician position has been funded together with an equipment for metabolomics. The plan over 3 years is to create two further full time positions of technician/engineer which a part-time devoted to basic research in academic projects.

New ATIP-AVENIR

Julien SENESCHAL
Vitiligo is the most common depigmenting disorder, with a prevalence of approximately 1% in the world population. This disease involves complex combinatorial pathogenic effects, multiple susceptibility genes and unknown environmental triggers. A loss of epidermal melanocytes is the pathogenic hallmark of vitiligo. The dermatology team has a long lasting interest in pigmentary disorders especially vitiligo and has developed tools to model pigmented skin ex vivo for the last two decades. The major goal of the newly created ATIP-Avenir project is to develop a basic research program on inflammatory dermatoses, in particular vitiligo, which benefits already of an established clinical research programme.

---
INSERM U1035! - University of Bordeaux
Work
146 rue Léo Saignat - PE building south zone, 4th floor
33000 Bordeaux
Aquitaine
France
Work +33 557 57 13 73/74
sarah.lesjean@inserm.fr